3D Bio Holdings, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2019-04-104/10/19 | New | $5,029,995 | $5,029,995 | Equity Only | 06b | SEC linkSEC |
| 2017-07-137/13/17 | New | $2,200,000 | $2,200,000 | Debt Only | 06c | SEC linkSEC |
| 2017-04-104/10/17 | New | $25,000 | $25,000 | Debt Only | 06c | SEC linkSEC |
| 2016-08-128/12/16 | Amended | $500,000 | $250,000 | Debt Only | 06b | SEC linkSEC |
| 2016-05-275/27/16 | New | $250,000 | $250,000 | Debt Only | 06b | SEC linkSEC |
| 2016-05-195/19/16 | Amended | $705,000 | $440,000 | Debt Only | 06b | SEC linkSEC |
| 2016-01-041/4/16 | New | $265,000 | $265,000 | Debt Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Michael G. Bator | Director |
| Daniel L. Cohen | Director, Executive |
| Matthew A. Fitzpatrick | Director |
| Harlan F. Weisman | Director |
Industry: Biotechnology (See others in industry)
Address:
2 St. Nicholas Avenue Suite 53
Brooklyn, NY, 11237
Phone: 212-922-9225
Brooklyn, NY, 11237
Phone: 212-922-9225